Shanghai, China

Wanting Xiong

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Inventor Spotlight: Wanting Xiong**

Introduction

Wanting Xiong is an innovative inventor based in Shanghai, China. With a focus on macrocyclic compounds, she has made significant contributions to the field of pharmaceutical sciences. Her work is particularly noteworthy due to its potential applications in cancer treatment.

Latest Patents

The patent granted to Wanting Xiong is titled "Macrocyclic compounds and compositions, and methods of preparing and using the same." This invention pertains to macrocyclic compounds of Formula (I) and their pharmaceutically acceptable forms. The patent outlines pharmaceutical compositions containing these compounds, methods of preparing them, and methods for treating cancer that depend on a farnesylated protein.

Career Highlights

Wanting Xiong is currently employed at Kura Oncology, Inc., a company dedicated to the development of innovative cancer therapies. Her work at the company emphasizes her dedication to advancing medical research and finding new solutions for cancer treatment.

Collaborations

Throughout her career, Wanting has collaborated with talented professionals, including her coworkers Xuefeng Zhu and Pingda Ren. These collaborations showcase the importance of teamwork in research and innovation within the pharmaceutical industry.

Conclusion

Wanting Xiong is a prominent inventor making strides in the pharmaceutical field, specifically in cancer treatment through her innovative patent on macrocyclic compounds. Her contributions reflect her commitment to advancing scientific understanding and enhancing the quality of healthcare. As research and innovation continue to evolve, inventors like Wanting will undoubtedly play a crucial role in shaping the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…